Post-IPO Equity - Celcuity
Investment Firm
Overview
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Announced Date
May 30, 2024
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
4
Round Details and Background
Celcuity raised $60000000 on 2024-05-30 in Post-IPO Equity
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Company Funding History
13
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 30, 2024 |  Post-IPO Equity - Celcuity | 6 | - | 60.0M |
| May 30, 2024 | Post-IPO Debt - Celcuity | 1 | - | 62.0M |
| Feb 26, 2016 | Venture Round - Celcuity | - | 5.2M | |
| Mar 24, 2014 | Series A - Celcuity | 1 | - | 4.0M |
Recent Activity
There is no recent news or activity for this profile.